Qing Tian Niu
Research Subjects
Research Interests
Qing Tian Niu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Gang Wu
School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology , Wuhan
1 shared publication- Jiaan Yang
Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences , Shenzhen, Guangdong
1 shared publication Lan Yang
Thousand Oaks Biologics Inc. , Nantong, Jiangsu
1 shared publication- Lianshan Zhang
Department of Oncology Clinical Research & Development, Jiangsu Hengrui Pharmaceuticals Co. Ltd, Shanghai, China;Department of Research & Development, Jiangsu Hengrui Pharmaceuticals Co. Ltd, Shanghai, China
1 shared publication - Peng Zhang
Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences Shenzhen China
1 shared publication Shun Luo
Thousand Oaks Biologics Inc. , Nantong, Jiangsu
1 shared publication
Latest Publications
- Open Access
- 1 June 2022
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 6 (6) , 344-355
Severe Acute Respiratory Syndrome Coronavirus 2 Epitope Mapping for Antibodies
Epitope mapping of the interactions between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Abs is challenging because of complexity in protein three-dimensional structures. Protein structure fingerprint technology was applied for epitope mapping of 44 SARS-CoV-2 Abs with three-dimensional structure complexes. The results defined how the epitopes were distributed on SARS-CoV-2 and how the patterns of six CDRs from Abs participated in neutralization. Also, the residue–residue recognition revealed that certain residues had higher frequencies on the interfaces between SARS-CoV-2 and Abs, and the activity correlated with the physicochemical properties of the residues at the interface. Thus, epitope mapping provides significant lead information for development of epitope-based designs for Abs, vaccines, and diagnostic reagents. This is a bioinformatics project of structural data analysis; no animals or cells were used.
- 1 June 2022
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 6 (6) , 344-355
Open AccessSevere Acute Respiratory Syndrome Coronavirus 2 Epitope Mapping for Antibodies
Epitope mapping of the interactions between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Abs is challenging because of complexity in protein three-dimensional structures. Protein structure fingerprint technology was applied for epitope mapping of 44 SARS-CoV-2 Abs with three-dimensional structure complexes. The results defined how the epitopes were distributed on SARS-CoV-2 and how the patterns of six CDRs from Abs participated in neutralization. Also, the residue–residue recognition revealed that certain residues had higher frequencies on the interfaces between SARS-CoV-2 and Abs, and the activity correlated with the physicochemical properties of the residues at the interface. Thus, epitope mapping provides significant lead information for development of epitope-based designs for Abs, vaccines, and diagnostic reagents. This is a bioinformatics project of structural data analysis; no animals or cells were used.